chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pounding racing heart of over 111; fever of 102 degrees; ringing in both ears off and on; body ache; heavy chest; blood pressure went from 116/68 to 96/67; pain in arm; This is a spontaneous report from a contactable consumer, the patient. A 36-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0172; Expiration date: 31Aug2021) via an unspecified route of administration in the left arm on 28Apr2021 at 13:30 (at the age of 36-years-old), as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included hydroxyzine hydrochloride (HYDROXIZINE) for unspecified indication from unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient previously received codeine (MANUFACTURER UNKNOWN) and oseltamivir phosphate (TAMIFLU); both for unspecified indication from unknown date and experienced drug allergy and also received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729; Expiration date: 31Jul2021) via an unspecified route of administration in the left arm on 07Apr2021 at 14:30 (at the age of 36-years-old), as a single dose for COVID-19 immunisation. On 29Apr2021 at 01:00, the patient experienced pounding racing heart of over 111 (unspecified units) while resting for 7 hours straight, fever of 102 degrees, ringing in both ears off and on, body ache, heavychest, blood pressure went from 116/68 (unspecified units) to 96/67 (unspecified units) and pain in arm that felt absolutely horrible. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events pounding racing heart of over 111 while resting for 7 hours straight, fever of 102 degrees, ringing in both ears off and on, bodyache, body ache, heavychest blood pressure went from 116/68 to 96/67 and pain in arm was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Information has been received from a physicians assistant concerning a 4 month old pt who was vaccinated with a dose of Rotavirus G1 G2 G3 G4 P1 reassortant vaccine live (human Bovine). It was unk if medical attention was sought and no adverse experiences were reported. Additional information has been requested.
Varivax administered 9/8/03. Mom called child seen 9/18/03; red around immunization site, runny nose.
T 99.1, no other constitutional symptoms 8cm x 8 1/2cm localized reaction centered on VARIVAX injection with minimal bruising at KINRIX site. Evaluated 17:25 8/5; 52 hours after. Patient received vaccinations on Monday. The shot injection site has a large red area around it. Patient complains of itching in area. Patient's mother states that the area is getting better. Patient's mother has not given any medications. Patient received KINRIX and Varicella in the affected leg.
Six hours later I had violent chills, fever. The next day I had all joint pain that lasted a week. It triggered arthritis.
Got the vaccine, became unconscious just after the shot, waked up in a Hospital 2 days later; a severe allergic reaction to the vaccine.; A spontaneous report was received from consumer concerning a 65 year old male patient who received Moderna's COVID-19 vaccine (mRNA-1273) and woke up in a hospital 2 days later unable to remember anything.  The physician stated he suffered a severe allergic reaction to the vaccine/hypersensitivity.   The patient's medical history was not reported. Concomitant product use was not provided by the reporter.   The patient received first dose of two planned doses of mRNA-1273 (Batch number: unknown) on 9 Mar 2021 at unknown injection site for prophylaxis of COVID-19 infection.   On 9 Mar 2021, the patient did not remember anything after receiving the vaccine and woke up two days later in a hospital. The physician stated he suffered a severe allergic reaction to the vaccine. The event, unconscious just after the shot, waking up in a hospital 2 days later, is considered medically significant.    Treatment for the events are not known.  Action taken with mRNA-1273 in response to the event(s) was not provided.  The outcome of the event, waking up in a hospital 2 days after receiving the vaccine, was considered resolved. The outcome of the event, severe allergic reaction to the vaccine, was not reported.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
This spontaneous report as received from a healthcare worker refers to a patient of an unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 12-APR-2016, the patient was vaccinated with a dose of improperly stored RECOMBIVAX HB 5/0.5 microgram/ml, lot # L033343 with expiration date: 13-SEP-2017, via intramuscular route (dose was not reported). Administered dose of RECOMBIVAX HB underwent temperature excursion at 31.1 Fahrenheit degrees, for 82 hours. There was no previous temperature excursion. There was no adverse effect reported. Product quality complaint (PQC) was not involved. This is one of several reports received from the same source. Additional information has been requested.
got COVID; This spontaneous case was reported by an other health care professional and describes the occurrence of SARS-COV-2 TEST POSITIVE (got COVID) in a 46-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure high. Concomitant products included ASPIRIN [ACETYLSALICYLIC ACID], ATORVASTATIN CALCIUM (LIPITOR), VITAMIN D NOS, VITAMIN C [ASCORBIC ACID] and ZINC for an unknown indication.    On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced SARS-COV-2 TEST POSITIVE (got COVID). At the time of the report, SARS-COV-2 TEST POSITIVE (got COVID) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The patient tested negative for COVID-19 on 14-Mar-2021. Other concomitant medication included high blood pressure medicines. Treatment information was not reported.
Bad abdominal pain; Fever; Headache; Aches; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of ABDOMINAL PAIN (Bad abdominal pain), PYREXIA (Fever), HEADACHE (Headache) and MYALGIA (Aches) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No adverse event).    On 05-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1. On 05-Jan-2021, the patient experienced PYREXIA (Fever), HEADACHE (Headache) and MYALGIA (Aches). On 06-Jan-2021, the patient experienced ABDOMINAL PAIN (Bad abdominal pain). At the time of the report, ABDOMINAL PAIN (Bad abdominal pain), PYREXIA (Fever), HEADACHE (Headache) and MYALGIA (Aches) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.   Reporter did not allow further contact; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
20 yo male c/o anterior chest pain and mild shortness of breath which started 4 days after receiving smallpox vaccination (13Jul06).  His symptoms were initially some fever (subjective), chills and malaise.  However these sx resolved and the chest discomfort continue to increase in intensity and not related to position.  Pain describe as "needles" over on his heart.  PE: normal, EKG was showing abnormal ST segments throughout most leads.  Admitted to telemetry at hospital.   Chest discomfort diminished at the time of discharge. DX: myopericarditis.  DX: Acute Pericarditis
pt recv vax 18OCT95 & w/in a few hr post vax pt devel achy joints, followed by fever & itchy skin, w/o rash;
tdap (adacel) vaccine while administering the portion of the syringe that you rest your fingers broke off and caused a laceration to the employees finger; Initial information received on 03-Aug-2023 regarding an unsolicited valid non-serious case received via other health professional.  This case involves an unknown age female patient, diphtheria-2/tetanus/5 AC pertussis vaccine [adacel] vaccine while administering the portion of the syringe that you rest your fingers broke off and caused a laceration to the employees finger.  The patient's past medical history, medical treatment(s), vaccination(s), concomitant(s) and family history were not provided.   On an unknown date, the patient received an unknown dose of suspect diphtheria-2/tetanus/5 AC pertussis vaccine Suspension for injection (strength, expiry date: unknown) (lot: U7869AA) via unknown route in unknown administration site for prophylactic vaccination (immunization).  On an unknown date the patient had event of tdap (adacel) vaccine while administering the portion of the syringe that you rest your fingers broke off and caused a laceration to the employees finger (skin laceration) (unknown latency) following the administration of diphtheria-2/tetanus/5 AC pertussis vaccine.  It was reported "Yesterday we had a nurse that was given a Tdap (Adacel) vaccine while administering the portion of the syringe that you rest your fingers broke off and caused a laceration to the employees finger. We did need to re-administer the vaccine as she was unable to give the medication".  Action taken with diphtheria, tetanus and acellular pertussis vaccine (Adacel) was not applicable.  It was not reported if the patient received a corrective treatment for the event.  Outcome: Unknown.
Chest pain radiating to Left arm with left numbness. No SOB. Left arm cool to touch and mottled.
Strong and sustained abdominal pain experienced beginning at 12:30 am on 9/4/2021.
pt. will receive 3 doses of T-dap/plans on administering; pt. will receive 3 doses of T-dap/plans on administering; This non-serious case was reported by a other health professional via call center representative and described the occurrence of circumstance or information capable of leading to medication error in a 8-year-old male patient who received DTPa (Reduced antigen) (Boostrix) for prophylaxis.   On an unknown date, the patient received Boostrix. On an unknown date, an unknown time after receiving Boostrix, the patient experienced circumstance or information capable of leading to medication error (Verbatim: pt. will receive 3 doses of T-dap/plans on administering) and inappropriate age at vaccine administration (Verbatim: pt. will receive 3 doses of T-dap/plans on administering).  The outcome of the circumstance or information capable of leading to medication error and inappropriate age at vaccine administration were unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK receipt date: 22-Aug-2023 The health care professional stated that 8 year old patient never received the D-tap.  According to cdc catch up schedule recommendations, this patient will receive 3 doses of T-dap.  The patient not in the office and has not received the boostrix but reporter plans on administering. No additional information was reported. Did not consent to follow-up. The patient will receive 3 doses of T-dap and has not received the boostrix but reporter plans on administering, which led to circumstance or information capable of leading to medication error and inappropriate age at vaccine administration.
Pt recvd 1st dose of Engerix-B in the AM & exp rash on upper chest both arms which lasted 2 hrs; dx dry skin, poss rash secondary to Hep B shot; rash-red, blotchy;
Fever (102.9), intense chills - trembling, teeth chattering. Also severe weakness and aches.
30 minutes after injection- right side of face and head went numb  90 minutes after injection- uncontrollable laughing  5 hours after- body aches 7 hours after- high fever, intense upper back pain, joint pain, aches, headache, chills, incredible thirst, nausea Uncontrollable laughing lasted about 5 minutes and happened at 2 separate times High fever lasted 24 hours Low grade fever lasted 72 hours  Nausea and thirst lasted 7 days  Numbness is still present to date
menstrual cycle was delayed by 2-3 weeks; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 26 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 20Dec2021 18:30 (Lot number: FJ8757) at the age of 26 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "Asthma" (unspecified if ongoing); "Known allergies: strawberries" (unspecified if ongoing). There were no concomitant medications. Past drug history included: Ciprofloxacin, reaction(s): "Known allergies: Ciprofloxacin", notes: ciprofloxacin; Gadolinium, reaction(s): "Known allergies: Gadolinium", notes: Gadolinium. Vaccination history included: Bnt162b2 (Dose: 2, lot number: EN6205, administration time: 08:00 AM, at Left arm), administration date: 13Mar2021, when the patient was 25 years old, for covid-19 immunization, reaction(s): "my neck was itchy"; Bnt162b2 (Dose: 2, lot number: EN6205, administration time: 08:00 , at Left arm), administration date: 13Mar2021, when the patient was 25 years old, for Covid-19 immunization, reaction(s): "hives on my left forearm"; Bnt162b2 (DOSE: 1, lot number: EN6198, administration time: 08:00 PM, dose vaccine location: Left arm), administration date: 20Feb2021, when the patient was 25 years old, for Covid-19 Immunization. The following information was reported: MENSTRUATION DELAYED (non-serious) with onset 01Jan2022, outcome "recovering", described as "menstrual cycle was delayed by 2-3 weeks". Therapeutic measures were not taken as a result of menstruation delayed.  Additional information: The patient had not receive any other vaccine in four weeks. The patient was not on other medication in past two weeks. No Covid prior vaccination. No Covid tested post vaccination.  Follow-up attempts are completed. No further information is expected.
UNBEARABLE CHEST PAIN; This spontaneous report received from a consumer concerned a male of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose was not reported, administered on 24-DEC-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On an unspecified date, the patient experienced unbearable chest pain. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of unbearable chest pain was not reported. This report was non-serious.
About 5 minutes after receiving both vaccines, patient stated that she had a left-sided headache and felt like her head wanted to explode. Her face flushed, her eyes became red and watery. She started to have SOB and wheezing. The heart rate increased from the 120's - 130's from 99.
This spontaneous report as received from nurse practitioner on behalf of the physician refers to a 12 year old female patient with Von Willebrand disease. On 18-JUN-2014 the patient was vaccinated with GARDASIL (first dose, 0.5 ml, intramuscular) (lot number J013777 with expiry date of 11-AUG-2016) in her left deltoid region. On the same day of vaccination, the patients mother contacted the physician and stated that her daughter experienced itchy, large welts and hives starting at the left deltoid GARDASIL injection site later in the evening of the same day of vaccination which progressed to further down on her arm and then move throughout her entire body later in the evening to her arms, legs and trunk. Adverse events were further described by the physician to nurse that patient possibly experienced an allergic reaction to GARDASIL. The patient was treated with BENADRYL (orally). The outcome of the events was unknown. The causality of the events with GARDASIL was not reported. There was no patient overdose and product quality issue involved. This case is linked to same patient link# 1406USA010867. Additional information has been requested.
Patient S developed hematoma left side of foot--purple discoloration entire foot . She sought treatment at Patient First on 7/11/21 but was not given any medication or treatment. On 7/12/21 ankle swelling began and she went to ER. Patient S got blood test done according to patient which showed no blood clot. She then called to get second opinion from. No treatment was given. Patient continues to have swelling of entire left foot.
Office visit 01/17/07 + pustular lesions on trunk/head/face varicella diagnosis.
She tested positive for Covid-19; This is a spontaneous report from a contactable consumer (patient) from a Pfizer sponsored program, COVAX US Support. A female patient of unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via unspecified route of administration on 21Apr2021 at single dose for COVID-19 immunization. Patient medical history and concomitant medications were not reported. The patient received her first dose of the vaccine last 21Apr2021. She tested positive for Covid-19 on unspecified date in May2021 (exact onset date after vaccination was not provided). Patient asked if she can still take her second dose of the vaccine scheduled on 12May2021. She mentioned that it will be more than 10 days after she presented the symptoms of Covid-19 on 12May2021. Outcome of the event was unknown.  Information on the lot/batch number has been requested.
day or two after some soreness in arm 9 days after - swelling and redness of arm.  Lots of redness at injection site.  Swollen area is warmer than rest of arm.  Some minor pain.
Employee reports immediate pain with actual injection, followed by continuous shoulder joint pain, beginning 1/2 hour after injection, has continued, is exacerbated with certain arm movements.  NSAID trial ordered 10/15/19; re-evaluation appt. 10/23/19.
Headache, nausea, chills, fever, left arm hurting and i couldn't get out of bed for 2 days
RUE - Approx 2" superior to the elbow - 6cm area of erythema and induration - warm to touch. No discharge, nontender.
Pt developed, swelling elbow, and R side of neck, R eye, 3 days after vaccination and states she felt hot, but no fever detected.
This spontaneous report as received from a physician via company representative refers to a patient of unknown gender. On an unknown date, an 8 year old patient was vaccinated with a first dose of GARDASIL injection (strength, route, lot number and expiration date not provided). The patient received the remaining 2 doses of GARDASIL on schedule. No adverse symptoms were reported. Additional information has been requested.
One hour after vaccine was given patient stated having severe coughing and had to come to ER.
12 hours after injection fever, chills, ague, extreme fatigue lasting 12 hours. 15 hours later loss of taste & smell lasted for 6 hours. Ague & extreme tiredness lasted 48 hours
revaccination of a second dose of GARDASIL 9 which was given at a 30 day interval after the first dose; This spontaneous report has been received from an unspecified source referring to a 26 year old male patient. Information regarding the patient's medical history, drug reactions or allergies, concurrent conditions and concomitant medications was not provided.      On an unknown date, the patient was vaccinated with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) for prophylaxis.       On 06-JAN-2021, the patient experienced inappropriate schedule of product administration.
Complications; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Complications) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Oct-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Complications). At the time of the report, VACCINATION COMPLICATION (Complications) outcome was unknown.            No concomitant medication was reported. No treatment medications was reported.
At 3 am on 11/6/21, had fever, chills, uncontrollable shaking, body aches.  On 11/7/21 8 am, swollen lymph nodes the size of golf balls, couldn't put arm down due to pain.  Pain went up to neck, across chest.  Swelling, red, hot, injection site.  General swelling in left arm (injection arm).  As of 11/11/21, still cannot take wedding ring off due to swelling.  Have had a headache since injection that has not subsided.  Taken Excedrin, Ibuprofen with no relief. Still warm and a lump at injection site, but the lump has decreased in size.  Missed work on 11/6/21 and 11/7/21 due to symptoms.
swelling, soreness, hard to raise arm, redness all the way wrapped around from deltoid muscle to front and bottom of biceps, cramping of bicep muscle
Body aches went from injection site to left side of my face. fever chills, sore arm for 2 weeks.
Headache, Myalgia, Fever, SkinRash, Rash, RASH ON FACE, FATIGUE,CHILLS,BODYACHES,HEADACHE,WEAK,FEVER Narrative:
Slight headache, major shoulder pain at site of injection, body aches, diaharrea
Slight lump in throat, of the kind experienced with previous anaphylaxis episodes, that developed a couple of hours after vaccination,  and is continuing.